FDA News Digest

["U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx>]

Title: FDA News Digest

---

Important Notice for FDA News Digest Subscribers

 

The Aug. 18 issue of FDA News Digest will be our last in the current format. Because it is now possible, through the GovDelivery subscription management system, for you to subscribe only to the information items that interest you (such as FDA news, recall notices, consumer features, etc.), we are discontinuing the News Digest.

 

To learn more and to see the full listing of information available from FDA by e-mail, go to http://www.fda.gov/emaillist.html.

---

FDA News Digest

August 4, 2008

_____________________________________

IN THIS WEEK'S ISSUE

 

»  News

    -- FDA Clears Test That Helps Identify Type of Cancer in Tumor Sample

    -- Generic Versions of Depakote OK'd for Seizures, Migraines, Bipolar Disorder

    -- Federal Agents Seize More than $24 Million in Unapproved New Drugs

    -- Report Identifies Factors Related to FDA Approval Decisions in First-Cycle Reviews 

»  Safety Alerts/Recalls

»  Upcoming Public Meetings

»  Consumer Health Information

__________________________________________

NEWS

 

FDA Clears Test That Helps Identify Type of Cancer in Tumor Sample

FDA has cleared for marketing a test that can help health care professionals determine what type of cancer cells are present in a malignant tumor. The Pathwork Tissue of Origin test compares the genetic material of a patient’s tumor with genetic information on malignant tumor types stored in a database. The test considers 15 common malignant tumor types, including bladder, breast, and colorectal tumors.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01870.html 

 

Generic Versions of Depakote OK'd for Seizures, Migraines, Bipolar Disorder

FDA has approved the first generic versions of Depakote delayed-release tablets (divalproex sodium) for treatment of seizures, migraine headaches, and bipolar disorder. The generic versions will have the same safety warnings as the name brand versions.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01867.html 

 

Federal Agents Seize More than $24 Million in Unapproved New Drugs

FDA representatives and U.S. marshals have seized $24.2 million worth of unapproved new drugs from St. Louis-based KV Pharmaceutical Co. The seizure followed an inspection of company plants that showed the company was manufacturing unapproved new drugs such as products for cough, cold, topical wound healing, skin bleaching, and gastrointestinal conditions, as well as narcotic drug products.

http://www.fda.gov/bbs/topics/NEWS/2008/NEW01868.html 

 

Report Identifies Factors Related to FDA Approval Decisions in First-Cycle Reviews 

A final report of FDA’s first-cycle review performance is available online. This study identifies factors that contribute to and detract from FDA’s ability to make approval decisions during the first-cycle review for products that are ultimately approved without major new data submissions.

http://www.fda.gov/ope/pdufa/PDUFA1stCycle/default.htm 

 

To view an archive of recent FDA news releases, go to

http://www.fda.gov/opacom/hpnews.html.

   

To access the RSS feed of FDA news releases, go to

http://www.fda.gov/bbs/topics/news/rssPress.xml.

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]

_____________________________________________

 

SAFETY ALERTS/RECALLS

 

For a complete list of recalls, market withdrawals, and safety alerts involving FDA-regulated

products from the past 60 days, go to http://www.fda.gov/opacom/7alerts.html. 

 

To access the RSS feed of FDA recalls information, go to

http://www.fda.gov/oc/po/firmrecalls/rssRecalls.xml  

[What is an RSS feed? See http://www.fda.gov/bbs/topics/news/newsfeeds.html.]  

____________________________________________________________________

 

UPCOMING PUBLIC MEETINGS

 

Sept. 8-10 -- Parenteral Drug Association (PDA)/FDA Joint Regulatory Conference

    Location: Washington, D.C.

http://www.pda.org/webmodules/webarticles/templates/new_conferences_2008_PDA_FDA.aspx?articleid=1453&zoneid=190

 

Sept. 10-12 -- Parenteral Drug Association (PDA)/FDA Pharmaceutical Ingredient Supply Chain Conference

    Location: Washington, D.C.

http://www.pda.org/webmodules/webarticles/templates/2008_PDA-FDA_Pharmaceutical_Ingredient_Supply_Chain_Conference.aspx?articleid=1803&zoneid=233

 

For a complete list of upcoming meetings, seminars, and other public events sponsored

or co-sponsored by FDA, go to http://www.fda.gov/opacom/hpmeetings.html.

 

 

CONSUMER HEALTH INFORMATION

 

Consumer updates in the spotlight this week are:

 

›  Living with Fibromyalgia, Drugs Approved to Manage Pain

http://www.fda.gov/consumer/updates/fibromyalgia062107.html  

› Stronger Warnings Requested for Fluoroquinolones

http://www.fda.gov/consumer/updates/fluoroquinolone070908.html

 

To receive all consumer updates by e-mail, go to http://www.fda.gov/consumer/consumerenews.html.

For the latest in consumer health news from FDA, visit http://www.fda.gov/consumer/default.htm. 

 

 

Check out "Andy's Take," a commentary from FDA's commissioner.

Go to http://www.fda.gov/oc/vonEschenbach/andys_take/default.html

_____________________________________________________________

 

Thanks for subscribing to FDA News Digest. 

Our next issue will be sent August 11.  

 

Comments about FDA News Digest?

Send an e-mail to fdanewsdigest@xxxxxxxxxv.

 

 

---

Update your subscriptions, modify your e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact support@xxxxxxxxxxxxxxx.

This service is provided to you at no charge by U.S. Food & Drug Administration (FDA).

GovDelivery, Inc. sending on behalf of U.S. Food & Drug Administration (FDA) · 5600 Fishers Lane · Rockville MD 20857 · 800-439-1420